BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671
1685 results:

  • 1. In Vitro Inhibition of Colorectal Cancer Gene Targets by
    Macharia JM; Pande DO; Zand A; Budán F; Káposztás Z; Kövesdi O; Varjas T; Raposa BL
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation treatment for adolescent and adult Tlymphoblastic leukemia /lymphoma: a large cohort multicenter study in China.
    Luo L; Jiao Y; Li Y; Yang P; Gao J; Huang S; Huang W; Wang J; Dong F; Ke X; Zou D; Gao C; Jing H
    Ann Hematol; 2024 Jun; 103(6):2073-2087. PubMed ID: 38581546
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.
    Draye-Carbonnier S; Camus V; Becker S; Tonnelet D; Lévêque E; Zduniak A; Jardin F; Tilly H; Vera P; Decazes P
    Sci Rep; 2024 Apr; 14(1):8033. PubMed ID: 38580734
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Peripheral T cell lymphoma initially presenting in lung biopsies: A diagnostic challenge.
    He L; Gao X; Meng F; Chen J; Shi Q; Zhao L; Yang J; Zhou Q; Wu H; Li W; Li Z
    Pathol Res Pract; 2024 Apr; 256():155234. PubMed ID: 38471291
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
    Nguyen Y; Nocturne G; Henry J; Ng WF; Belkhir R; Desmoulins F; Bergé E; Morel J; Perdriger A; Dernis E; Devauchelle-Pensec V; Sène D; Dieudé P; Couderc M; Fauchais AL; Larroche C; Vittecoq O; Salliot C; Hachulla E; Le Guern V; Gottenberg JE; Mariette X; Seror R
    Lancet Rheumatol; 2024 Apr; 6(4):e216-e225. PubMed ID: 38437852
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/lymphoma from Multicenter].
    Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
    Yang R; Ai Y; Bai T; Lu XX; He G
    Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
    Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
    Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Management of ALL in adults: 2024 eln recommendations from a European expert panel.
    Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
    Blood; 2024 May; 143(19):1903-1930. PubMed ID: 38306595
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 eln recommendations from a European expert panel.
    Gökbuget N; Boissel N; Chiaretti S; Dombret H; Doubek M; Fielding A; Foà R; Giebel S; Hoelzer D; Hunault M; Marks DI; Martinelli G; Ottmann O; Rijneveld A; Rousselot P; Ribera J; Bassan R
    Blood; 2024 May; 143(19):1891-1902. PubMed ID: 38295337
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
    Abrahão R; Brunson A; Chubak J; Wernli KJ; Nichols HB; Chao C; Ruddy KJ; Hahn EE; Li Q; Malogolowkin MH; Sauder CAM; Kushi LH; Wun T; Keegan THM
    Thromb Res; 2024 Mar; 235():1-7. PubMed ID: 38244373
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes.
    Rajakumaraswamy N; Gandhi M; Wei AH; Sallman DA; Daver NG; Mo S; Iqbal S; Karalliyadda R; Chen M; Wang Y; Vyas P
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):260-268.e2. PubMed ID: 38216397
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
    Moore-Vasram S; Sawhney M; Houlden RL; Groome PA; Goldie C; Li W; Hay AE; Tranmer J
    Can J Diabetes; 2024 Apr; 48(3):195-203.e1. PubMed ID: 38211830
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
    Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
    Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML).
    Schittenhelm MM; Kaiser M; Győrffy B; Kampa-Schittenhelm KM
    Cell Death Dis; 2024 Jan; 15(1):25. PubMed ID: 38195541
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.
    Tao Y; Wei L; Shiba N; Tomizawa D; Hayashi Y; Ogawa S; Chen L; You H
    Mol Biomed; 2024 Jan; 5(1):1. PubMed ID: 38163849
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. THE STRUCTURE OF THE INCIDENCE OF ONCOHEMATOLOGICAL DISEASES IN ECOLOGICALLY DISADVANTAGED REGIONS OF THE DNIPROPETROVSK REGION FOR THE PERIOD 2006-2017.
    Selina IO; Dyagil IS
    Probl Radiac Med Radiobiol; 2023 Dec; 28():404-415. PubMed ID: 38155136
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis.
    Sutter T; Schittenhelm M; Volken T; Lehmann T
    Hematology; 2023 Dec; 28(1):2206694. PubMed ID: 38078486
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States.
    Shen C; Thornton JD; Li N; Schaefer E; Zhou S; Kawasaki S; Pameijer C; Leslie D
    Oncologist; 2024 Feb; 29(2):176-184. PubMed ID: 37944042
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Stem cell-like reprogramming is required for leukemia-initiating activity in B-ALL.
    Fregona V; Bayet M; Bouttier M; Largeaud L; Hamelle C; Jamrog LA; Prade N; Lagarde S; Hebrard S; Luquet I; Mansat-De Mas V; Nolla M; Pasquet M; Didier C; Khamlichi AA; Broccardo C; Delabesse É; Mancini SJC; Gerby B
    J Exp Med; 2024 Jan; 221(1):. PubMed ID: 37930337
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 85.